<DOC>
	<DOCNO>NCT01150461</DOCNO>
	<brief_summary>The purpose study determine whether take losartan help people hypertrophic nonobstructive cardiomyopathy feel well decrease amount heart muscle thicken and/or amount heart muscle scarring .</brief_summary>
	<brief_title>Effect Losartan Patients With Nonobstructive Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description>Hypertrophic cardiomyopathy ( HCM ) characterize idiopathic cardiac hypertrophy , heart failure , ischemia even absence epicardial coronary artery disease , arrhythmia . The pathological feature HCM include hypertrophy disarray , interstitial fibrosis , increase arteriolar wall thickness . Hypertrophy fibrosis major determinant morbidity mortality hypertrophic cardiomyopathy . Some investigator demonstrate interstitial fibrosis hypertrophy occur secondarily , response trophic mitotic factor heart . Therefore , block trophic factor may attenuate potentially reverse hypertrophy fibrosis HCM . Angiotensin II trophic profibrotic effect heart , blockade angiotensin II type I receptors show attenuate myocardial hypertrophy fibrosis acquire cardiac disease human animal model . We hypothesize treatment selective angiotensin II type receptor antagonist , losartan , decrease hypertrophy fibrosis , improve diastolic function , reduce symptom , improve functional status patient HCM .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<criteria>Patients hypertrophic cardiomyopathy Left ventricular outflow tract ( LVOT ) gradient le 30 mm Hg rest Age 18 year old Contraindication losartan Already take losartan Contraindication MRI Hemodynamic instability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Hypertrophic nonobstructive cardiomyopathy</keyword>
</DOC>